All In MedTech

Device Trial Radar · NCT02316782

Bifurcation Lesion Analysis and STenting / BLAST

Last checked: Nov 20, 2026Latest source record: Jun 17, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

Completed

Status

Completed

Enrollment

195

Actual

Start

Oct 2008

Primary completion

Dec 2010

Study completion Dec 2013

Sponsor

Lead sponsor
Volcano CorporationNot on our public-company list
Sponsor type
Industry
First posted
Dec 15, 2014

More device trials from this sponsor

Design

Study type
Observational
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this research study is to determine if Intravascular Ultrasound (IVUS) grayscale and VH (Virtual Histology)-IVUS pre-stenting can assess more accurately the location, amount, and type of a blockage than angiogram alone. Additionally, this study is to determine if IVUS grayscale and VH-IVUS guidance will result in improved acute and long term procedural outcome vs. bifurcation stenting with only angiographic guidance in native coronary arteries.

Conditions

  • Coronary Atherosclerosis

Interventions

  • Blinded IVUS assessmentDevice

    Only the angiogram is used for stent placement

  • Nonblinded IVUSDevice

    Angiogram, Grayscale IVUS and VH IVUS used for stent placement pre and post intervention

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. IVUS with VH guidance leads to better post procedural outcomes when comparedTime frame: 2 years

Locations

10 sites in 8 countries. Site status is shown where the registry gives one.

  • Saint Luke's Hospital-Mid America Heart Institute

    Kansas City, Missouri

  • Kardiologisk laboratorium/B-lab Skejby Sygehus

    Aarhus, Denmark

  • Clinique Saint Augustin

    Bordeaux, France

7 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.